Insider · CIK 0001870913
Muthusamy Shanmugam
Files at ANIP (ANI PHARMACEUTICALS INC). First filing May 13, 2025, latest Aug 22, 2025.
Muthusamy Shanmugam files SEC Form 4 as COO and director at ANIP (ANI PHARMACEUTICALS INC). Since May 13, 2025, Muthusamy Shanmugam has reported 0 open-market buys worth $0 and 3 open-market sells worth $18M, the latest filed on Aug 22, 2025.
A track record needs three past buys with six months of prices behind them; Muthusamy Shanmugam has 0, so none is measured yet.
The newest scored trade: sold $9.0M of ANIP on Aug 20, 2025, filed Aug 22, 2025, scored 65 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANIP: ANI PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | ANI PHARMACEUTICALS INC | $9.0M 100,000 shares | -19% | +70% from low0% from high | |
| 65Notable | ANI PHARMACEUTICALS INC | $8.8M 100,000 shares | -16% | +69% from low0% from high | |
| 22Weak | ANI PHARMACEUTICALS INC | $54k 700 shares | -0% | +24% from low-9% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 21, 2025 | ANIP ANI PHARMACEUTICALS INC | 52,988 0.24% of outstanding | $4.8M | Aug 21, 2025 | $13M |
| Aug 20, 2025 | ANIP ANI PHARMACEUTICALS INC | 47,012 0.22% of outstanding | $4.2M | Aug 20, 2025 | $8.8M |
| Aug 15, 2025 | ANIP ANI PHARMACEUTICALS INC | 52,990 0.24% of outstanding | $4.6M | Aug 15, 2025 | $4.2M |
| Aug 14, 2025 | ANIP ANI PHARMACEUTICALS INC | 47,010 0.22% of outstanding | $4.2M | Aug 14, 2025 | none |
| May 12, 2025 | ANIP ANI PHARMACEUTICALS INC | 700 0.00% of outstanding | $54k | May 9, 2025 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +11,116 | $77.15 | $858k | 101,056 | Mar 2, 2026 |
| Feb 11, 2026 | ANIP ANI PHARMACEUTICALS INC | FTax withholding Common Stock | -2,898 | $76.25 | $221k | 89,940 | Feb 13, 2026 |
| Aug 20, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: Held by Esjay LLC | -47,012 | $90.27 | $4.2M | 484,908 | Aug 22, 2025 |
| Aug 21, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: Held by Esjay LLC | -52,988 | $90.44 | $4.8M | 431,920 | Aug 22, 2025 |
| Aug 14, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: Held by Esjay LLC | -47,010 | $89.48 | $4.2M | 584,910 | Aug 18, 2025 |
| Aug 15, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: Held by Esjay LLC | -52,990 | $87.15 | $4.6M | 531,920 | Aug 18, 2025 |
| May 9, 2025 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stockindirect: Held by Esjay LLC10b5-1 | -700 | $76.83 | $54k | 631,920 | May 13, 2025 |
| Feb 12, 2025 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +14,362 | $0.00 | $0 | 83,014 | Feb 18, 2025 |
| Feb 12, 2025 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +9,574 | $0.00 | $0 | 92,588 | Feb 18, 2025 |
Questions about Muthusamy Shanmugam
Answered from the filings on this page, as of the latest one.
Is Muthusamy Shanmugam buying or selling?
Not in the last 12 months. Muthusamy Shanmugam's latest open-market trade on SEC Form 4 was sold $9.0M of ANIP on Aug 20, 2025.
How did Muthusamy Shanmugam's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Muthusamy Shanmugam has 0.
Where does Muthusamy Shanmugam file Form 4?
Muthusamy Shanmugam has filed Form 4 at ANIP (ANI PHARMACEUTICALS INC) as HEAD OF R&D, COO-NOVITIUM OPS. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.